Sagiment Biosciences Inc (SGMT)
NASDAQ
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 2M | 0 | 0 |
Operating Income | -6.77M | -7.06M | -7.45M | -9.47M | -8.77M |
Pre Tax Income | -6.59M | -6.79M | -6.35M | -8.15M | -6.63M |
Net Income | -6.59M | -6.79M | -6.35M | -8.15M | -6.63M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 |
EBIT | -6.77M | -7.06M | -7.45M | -9.47M | -8.77M |
EBITDA | -6.77M | -7.06M | -7.45M | -9.47M | -8.77M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 2M |
Operating Income | -23.72M | -31.06M | -30.74M |
Pre Tax Income | -24.44M | -30.5M | -27.88M |
Net Income | -24.44M | -30.5M | -27.88M |
Preferred Dividends | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.676 | -2.073 | -1.304 |
EBIT | -24.47M | -31.06M | -30.74M |
EBITDA | -23.72M | -31.06M | -30.74M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.